Litcius/Paper detail

First soluble TCR therapy opens ‘new universe’ of cancer targets

Elie Dolgin

2022Nature Biotechnology27 citationsDOI

Topics & Concepts

T-cell receptorCancerComputational biologyBiologyImmunologyGeneticsT cellImmune systemCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods
First soluble TCR therapy opens ‘new universe’ of cancer targets | Litcius